Medical Marijuana I Stock Current Valuation
| MJNA Stock | USD 0 0.0001 5.00% |
Valuation analysis of Medical Marijuana helps investors to measure Medical Marijuana's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Medical Marijuana's price fluctuation is out of control at this time. Calculation of the real value of Medical Marijuana is based on 3 months time horizon. Increasing Medical Marijuana's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Medical Marijuana I is useful when determining the fair value of the Medical pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Medical Marijuana. Since Medical Marijuana is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medical Pink Sheet. However, Medical Marijuana's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0021 | Real 0.001976 | Hype 0.00261 | Naive 0.001247 |
The real value of Medical Pink Sheet, also known as its intrinsic value, is the underlying worth of Medical Marijuana Company, which is reflected in its stock price. It is based on Medical Marijuana's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Medical Marijuana's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medical Marijuana's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medical Marijuana I helps investors to forecast how Medical pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medical Marijuana more accurately as focusing exclusively on Medical Marijuana's fundamentals will not take into account other important factors: Medical Marijuana I Company Current Valuation Analysis
Medical Marijuana's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medical Marijuana Current Valuation | 62.53 M |
Most of Medical Marijuana's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medical Marijuana I is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medical Marijuana I has a Current Valuation of 62.53 M. This is 99.56% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.62% higher than that of the company.
Medical Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medical Marijuana's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medical Marijuana could also be used in its relative valuation, which is a method of valuing Medical Marijuana by comparing valuation metrics of similar companies.Medical Marijuana is currently under evaluation in current valuation category among related companies.
Medical Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | -0.0146 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 62.53 M | |||
| Shares Outstanding | 3.44 B | |||
| Price To Earning | 5.25 X | |||
| Price To Book | 0.55 X | |||
| Price To Sales | 0.86 X | |||
| Revenue | 58.98 M | |||
| Gross Profit | 57.73 M | |||
| EBITDA | 1.45 M | |||
| Net Income | 84.4 M | |||
| Cash And Equivalents | 4.68 M | |||
| Total Debt | 10.41 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 1.92 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | 86.86 M | |||
| Earnings Per Share | 0 X | |||
| Number Of Employees | 91 | |||
| Beta | 1.12 | |||
| Market Capitalization | 56.49 M | |||
| Total Asset | 209.53 M | |||
| Retained Earnings | 31.14 M | |||
| Working Capital | 8.65 M | |||
| Current Asset | 14.02 M | |||
| Current Liabilities | 5.37 M | |||
| Z Score | 3.0 |
About Medical Marijuana Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medical Marijuana I's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Marijuana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Marijuana I based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Marijuana I. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Medical Pink Sheet analysis
When running Medical Marijuana's price analysis, check to measure Medical Marijuana's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Marijuana is operating at the current time. Most of Medical Marijuana's value examination focuses on studying past and present price action to predict the probability of Medical Marijuana's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Marijuana's price. Additionally, you may evaluate how the addition of Medical Marijuana to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |